AA (arachidonic acid), which possesses both neurotoxic and neurotrophic activities, has been implicated as a messenger in both physiological and pathophysiological processes. In the present study, we investigated the effects of both extracellular and intracellular application of AA on the activity of Na V (voltagegated Na + channels) in rat cerebellar GCs (granule cells). The extracellular application of AA inhibited the resultant I Na (Na V current), wherein the current-voltage curve shifted to a negative voltage direction. Because this effect could be reproduced by treating the GCs with ETYA (eicosa-5,8,11,14-tetraynoic acid) or a membrane-impermeable analogue of AA, AA-CoA (arachidonoyl coenzyme A), we inferred that AA itself exerted the observed modulatory effects on I Na . In contrast, intracellular AA significantly augmented the elicited I Na peak when the same protocol that was used for extracellular AA was followed. The observed I Na increase that was induced by intracellular AA was mimicked by the AA cyclo-oxygenase metabolite PGE 2 (prostaglandin E 2 ), but not by ETYA. Furthermore, cyclooxygenase inhibitors decreased I Na and quenched AA-induced channel activation, indicating that the effect of intracellular AA on Na V was possibly mediated through AA metabolites. In addition, the PGE 2 -induced activation of I Na was mimicked by cAMP and quenched by a PKA (protein kinase A) inhibitor, a G s inhibitor and EP (E-series of prostaglandin) receptor antagonists. The results of the present study suggest that extracellular AA modulates Na V channel activity in rat cerebellar GCs without metabolic conversion, whereas intracellular AA augments the I Na by PGE 2 -mediated activation of cAMP/PKA pathways. These observations may explain the dual character of AA in neuronal pathogenesis.
INTRODUCTION
AA (arachidonic acid), a polyunsaturated fatty acid liberated from membrane phospholipids by cellular phospholipases, plays many important roles in neurons under both physiological and pathological conditions. Application of glutamate results in dosedependent release of AA, suggesting that AA could be involved in sustained changes in synaptic efficacy and long-term potentiation [1, 2] . Massive amounts of AA are released during brain injury or brain ischaemia, suggesting that AA is likely to be involved in ischaemia-induced neuronal damage and cell death [3, 4] . Katsuki and Okuda [1] reported that AA showed quite distinct neurotoxic or neurotrophic actions within a narrow concentration range, depending on whether the action was mediated by free radicals generated by AA metabolism or by AA itself. A thorough study of the function of AA and the mechanism of its action would help to uncover the role of AA in brain pathogenesis and neural development.
AA acts as an important biologically active signalling molecule, eliciting many biological effects that include the modulation of the activity of protein kinases, increasing intracellular Ca 2 + levels and regulating neuronal excitability [2, 5, 6] . AA and its metabolites have been shown to modulate many ligand-and voltage-gated ion channels in diverse systems [7] ; these include NMDA (N-methyl-D-aspartate) receptor channels, voltage-gated Na + and K + channels, Ca 2 + -dependent K + channels and acidsensing ion channels [8] [9] [10] [11] . Activation or inactivation of these ion channels depends on the cell type studied [12, 13] and the mechanism involved [7] . The direct effects imply that AA might exert its modulating actions by directly interacting with ionchannel proteins or through perturbation of the plasma membrane [10, 14, 15] , whereas the indirect actions on ion channels are mediated by metabolites of AA through oxygenases or cellular signal transduction pathways [13] . However, in most previous studies AA was applied extracellularly, and few studies have investigated the effects of intracellular AA. Wieland et al. [16] reported that intracellular exposure to 1-20 μM AA increased the magnitude of voltage-activated Na + currents, but without further exploration of the mechanism. Because intracellular AA is more likely to be subject to enzymatic conversion into its metabolites, and thus better reflect the in vivo situation, it will be interesting to compare the differential effects of extracellular compared with intracellular AA and to investigate the underlying mechanisms.
Na V (voltage-gated Na + channels) are one of the primary classes of ion channels responsible for driving neuronal excitability in both the central and peripheral nervous systems. Na V are important in the clinic because they play the central role in the generation of neuronal activity and are key actors in a number of pathologies [17] . Previous studies have revealed that activation or up-regulation of Na V channels not only participates in the rising phase of the neuronal action potential, but also contributes to many cellular behaviours, including apoptosis, motility and secretory membrane activity [18] [19] [20] . Thus, although Na + currents are less sensitive to AA than K + currents [21] , the mechanism of AA regulation of Na + channels is of wide interest. GCs (granule cells) occupy a key position in the cerebellumcortex circuitry, forming the input layer of the major cerebellar afferent system. Cerebellar GCs grown in primary culture express TTX (tetrodotoxin)-sensitive Na V channels that determine the discharge of the GC action potential and the code relayed into the cerebellar circuitry [22, 23] . Therefore understanding the mechanisms of how GC Na V channel activity is regulated is of particular importance. We have shown previously that I Na amplitudes of cerebellar GCs are modulated by lipid products such as ceramide [22] . In the present study we used a whole-cell patch-clamp technique to investigate the effects of AA on Na V of cerebellar GCs and compared the effects of extracellular and intracellular AA. Our studies indicate that AA activates or inhibits I Na (Na V current) in rat cerebellar GCs depending on the route of AA application and that either non-metabolic or metabolic pathway are involved.
EXPERIMENTAL

Primary cell culture
All of the procedures regarding animal experiments were carried out in accordance with European guidelines for the care and use of laboratory animals (Council Directive 86/609/EEC).
Cells were derived from cerebellum of 7-day-old SpragueDawley rat pups as described previously [24] . Isolated cells were then plated on to 35-mm-diameter Petri dishes coated with poly-L-lysine (1 μg/ml) at a density of 2.5 × 10 5 /cm 2 . Cultured cells were incubated at 37
• C with 5 % CO 2 in DMEM (Dulbecco's modified Eagle's medium) supplemented with 10 % fetal bovine serum, glutamine (5 mM), insulin (5 μg/ml), KCl (25 mM) and 1 % antibiotic/antimycotic solution. All experiments were carried out with cerebellar GCs during 6-8 DIC (days in culture).
Patch-clamp recordings
Whole-cell currents of GCs were recorded using a conventional patch-clamp technique. In 6-8 DIC cerebellar GCs, transient I Na are largely unclamped because of an event generated at a site electrotonically distant from the soma and prone to escape from clamp control, presumably the axon [25] . Therefore, we chose those cells that were relatively isolated and only recorded currents without an unclamped spike. Prior to current recordings, the culture medium was replaced with a bath solution containing: 145 mM NaCl, 2.5 mM KCl, 10 mM Hepes, 1 mM MgCl 2 and 10 mM glucose (pH adjusted to 7.4 using NaOH). Soft glass recording pipettes were filled with an internal solution containing: 145 mM CsCl, 10 mM Hepes, 2 mM MgCl 2 and 5 mM EGTA (pH adjusted to 7.3 using CsOH). The pipette resistance was 5-6 M after filling with the internal solution. Whole-cell series resistances of 6-8 M were routinely compensated by more than 70 %. All recordings were performed at room temperature (23-25C
• ).
Data acquisition and analysis
All current signals were recorded with an EPC-7 patch-clamp amplifier (List Electronic) in the voltage-clamp mode. Current was digitally sampled at 100 μs (10 kHz RNA was isolated from GCs using an RNeasy Mini Kit (Qiagen). First-strand cDNA synthesis was performed on 3 μg of total RNA with MMLV (Moloney murine leukaemia virus) reverse transcriptase and oligo(dT)18 according to the manufacturer's instructions (Promega). A 2 μl aliquot of the total reverse transcription reaction volume (20 μl) was used as a template in semi-quantitative reverse transcriptase-mediated PCR amplification, ensuring that the amount of amplified product remained in linear proportion to the initial template present in the reaction. A 3 μl aliquot from the PCR was separated on a 1 % agarose gel. PCR using isolated RNA as template served as a negative control. Primers used were 5 -GCAAGCCAAG-GAGACTTCTGAA-3 and 5 -CGTCATGGAGAAGATAG-GCAGC-3 for PTGER 1 (NM_013100), 5 -CACCTCATT-CTCCTGGCCATTA-3 and 5 -GCCACCCGATGTGAACTT-TATG-3 for PTGER 2 (NM_031088.1), 5 -GGTATGCCAG-CCACATGAAGAC-3 and 5 -GGCGATTAGGAAGGAAT-TGCA-3 for PTGER 3 (NM_012704.1), 5 -TCGCCGTCTAT-GCATCTAACG-3 and 5 -TGTCTTTCACCACACTTGGCTG-3 for PTGER 4 (NM_032076.3).
Chemicals
All drugs used were purchased from Sigma-Aldrich. Fetal bovine serum, DMEM and antibiotic/antimycotic solution were obtained from Gibco Life Technologies. AA, ETYA (eicosa-5,8,11,14-tetraynoic acid), flufenamic acid, indomethacin, PMA, AH6809 and AH23848 were first dissolved in DMSO and then diluted in extracellular or intracellular solution, with a final DMSO concentration < 0.2 %, which did not affect I Na alone.
RESULTS
We first investigated the actions of extracellular AA on I Na . I Na was elicited by a depolarization step to − 10 mV from the holding potential of − 100 mV. When 10 μM AA was applied via gravity perfusion, we found that the amplitude of I Na began to decrease by approximately 29.3 % within 30 s (n = 13 for control and n = 4 for AA; P < 0.05) ( Figure 1A , left-hand panel). The effect of AA on the activation properties of I Na was then studied using appropriate voltage protocols. I Na were evoked by a 20 ms depolarizing pulse from a holding potential of − 100 mV to potentials between − 70 and 20 mV, with 5 mV steps at intervals of 5 s ( Figure 1B ). Figure 1 (C) illustrates a voltagecurrent curve in which the maximum activation potential changed from − 27.3 + − 0.9 mV to − 32.5 + − 2.5 mV in the absence or presence of AA (n = 13 for control and n = 4 for AA). We obtained steady-state activation of I Na by normalizing the conductance as a function of the command potential. As shown in Figure 1(D) , the half-activation potentials were changed from − 41.1 + − 0.9 mV to − 48.4 + − 1.9 mV in the presence of 10 μM AA (P<0.05) and the slope factors were 3.9 + − 0.2 mV and 4.8 + − 1.0 mV in the absence or presence of 10 μM AA, suggesting that extracellular AA significantly shifted the voltage-dependence property in the steady-state activation of I Na . To address whether the inhibitory effect of extracellular AA on I Na involved any AA metabolites, ETYA, the non-metabolized analogue of AA, was used. Application of ETYA to the bath solution mimicked the AA-induced inhibitory effect on I Na evoked by a depolarization of − 10 mV from the holding potential of − 100 mV and, as shown in Figure 1 (A) (right-hand panel), the I Na amplitudes were reduced by approximately 35.7 % (n = 13 for control and n = 5 for ETYA). Moreover, the average halfactivation potential was changed to − 47.6 + − 2.0 mV and the average slope factor was changed to 5.7 + − 0.7 mV in the presence of 10 μM ETYA (P<0.05, n = 7), similar to that induced by extracellular AA (Figures 1E and 1F) .
We then used AA-CoA (arachidonyl coenzyme A), an impermeable analogue of AA, to rule out the possibility of AA travelling into cytoplasm and consequently converting into its metabolites. Application of AA-CoA to the bath solution also mimicked the AA-induced modulation on I Na ( Figures 1E and  1F ). The addition of 10 μM AA-CoA decreased the I Na evoked from − 100 to − 10 mV by approximately 22.6 % and shifted the half-activated potential to − 50.9 + − 2.6 mV (S1 / 2 was 3.3 + − 0.9 mV) in the five cells tested (P < 0.05). All of the data obtained from extracellular application of AA, ETYA and AA-CoA suggest that extracellular AA blocks I Na on cerebellar GCs by the molecule itself, probably on the outside surface of the membrane.
The present study next investigated whether intracellular application of AA could produce similar effects on I Na as those observed upon extracellular application of AA. The I Na was elicited by a depolarization step to − 10 mV from the holding potential of − 100 mV. When 10 μM AA was delivered intracellularly via the pipette, we found that the amplitude of I Na increased with time after the establishment of the whole-cell configuration. Moreover, the effect of I Na activation induced by AA was concentration-dependent ( Figure 2A ). The I Na amplitude recorded 2 min after the establishment of the whole-cell configuration increased by 0.2 + − 1.8 % (n = 9), 13.3 + − 4.8 % (n = 8) and 38.8 + − 3.3 % (n = 7) with intracellular AA at concentrations of 1 μM, 10 μM and 50 μM respectively (P < 0.05 by one-way ANOVA test). To rule out the possibility that DMSO might contribute to the I Na response, a control solution containing 0.2 % DMSO was applied and the current amplitude changed from − 921.2 + − 72.2 pA to − 892.2 + − 58.4 pA, which was not significantly different (n = 4, P > 0.05). Statistical analysis of these data is shown in Figure 2 (B).
To examine whether intracellular AA could affect the steadystate activation property of Na V , the same experiment as that shown in Figures 1(B)-1(D) was repeated using intracellular AA. The effect of intracellular AA on the activation properties of I Na was also tested using a protocol of a 20 ms depolarizing pulse from a holding potential of − 100 mV to potentials between − 70 and 20 mV, with 5 mV steps at intervals of 5 s ( Figure 3A) . The voltage-current curve obtained from 15 cells showed that 10 μM AA raised the I Na peak elicited at every depolarization potential ( Figure 3B ). The maximum activation potential decreased from − 28.3 + − 1.4 mV to − 43.0 + − 1.2 mV in the presence of 10 μM intracellular AA. The normalized conductance as a function of the command potential, in the absence or presence of 10 μM AA, is presented in Figure 3 (C). The currents were half-activated at − 41.9 + − 1.4 mV and − 54.6 + − 0.9 mV, and the slope factors were 3.5 + − 0.6 mV and 2.1 + − 0.4 mV in the absence or presence of 10 μM AA respectively (P < 0.05, n = 10 for the control and n = 5 for AA), suggesting that intracellular AA significantly shifted the voltage-dependence property in the steady-state activation of I Na .
The present study then investigated the effects of intracellular AA on the voltage-dependence of steady-state inactivation of I Na channels. I Na was elicited using 1-s conditioning prepulses ranging from − 100 to − 40 mV, in steps of 5 mV prior to a − 10 mV test pulse. The curve illustrating the relationship between the I Na peak and the pre-pulse potential is shown in Figure 3(D) . The steadystate inactivation curve was then fitted using the Boltzmann
In the 11 cells studied (n = 6 for the control experiment and n = 5 for AA), V m 1 / 2 were − 61.7 + − 1.5 mV and − 59.8 + − 1.1 mV in the absence and presence of 10 μM AA respectively (P > 0.05) ( Figure 3E ). Intracellular AA did not significantly shift the steadystate inactivation curve.
Most biological activities of AA are conducted through its conversion into prostaglandins and other products by COX (cyclo-oxygenase), lipoxygenase and mono-oxygenase pathways [26] . Since COX-2 is reported to be abundant in brain neurons [27] , we wondered whether the COX-2 metabolite PGE 2 (prostaglandin E 2 ) was involved in the intracellular AA-induced modulation. We replaced the intracellular AA by PGE 2 and ETYA to check whether AA itself or its metabolic products was the direct effector on I Na . Application of 10 μM PGE 2 in the pipette solution mimicked the effect of AA on I Na ( Figures 4B and 4C) ; the current amplitude increased from − 1177.1 + − 105.5 pA to − 1477.8 + − 137.6 pA, by approximately 25.4 % (n = 7, P < 0.05).
In contrast, adding 10 μM ETYA to the intracellular solution gradually lowered I Na ( Figure 4D ), and the current amplitude decreased from − 1314.3 + − 113.8 pA to − 971.0 + − 122.0 pA, by approximately 27.2 % (n = 8, P < 0.05). To subtract the effect of the pipette solution on I Na , a normal intracellular solution was also tested as control. The control solution alone did not significantly affect I Na during a 2-min recording ( Figure 4A ). In some cases, I Na began to decline after 2 min, with the amplitude decreasing by 6.4 + − 0.9 % compared with the first recording (I 0 ) after membrane rupture (n = 8). Statistical analysis of these results is shown in Figure 4 (E). To confirm that PGE 2 was associated with the stimulatory effects of intracellular AA on I Na , the effect of PGE 2 and ETYA on the activation of I Na channels were compared using the same voltage protocols as used for AA. Figure 5(A) shows the original current obtained from neuron recordings with the intracellular solution containing 10 μM PGE 2 or 10 μM ETYA. The voltagecurrent curve obtained from 13 cells (n = 7 for PGE 2 and n = 6 for ETYA) showed that 10 μM PGE 2 raised the I Na peak elicited at every depolarization potential, which was similar to that induced by intracellular AA. However, intracellular ETYA brought about effects similar to those caused by its application extracellularly, but different from that of the intracellular application of AA or PGE 2 ( Figure 5B ). The normalized conductance as a function of the command potential, in the absence or presence of 10 μM PGE 2 or AA, is presented in Figures 5(C) and 5(D) . The currents were half activated at − 50.8 + − 1.6 mV and − 45.8 + − 0.7 mV in the absence or presence of 10 μM PGE 2 or ETYA respectively (P< 0.05, both compared with the control, n = 7 for PGE 2 and n = 6 for ETYA). There were no differences in the voltagedependence of the steady-state activation of I Na among PGE 2 and AA.
The effect of intracellular PGE 2 and ETYA on the voltagedependence of the steady-state inactivation of I Na was also compared using the inactivation voltage protocol ( Figure 6A ). In this protocol, current was elicited using 1 s conditioning prepulses ranging from − 100 to − 40 mV in steps of 5 mV prior to a − 10 mV test pulse. Figure 6(B) shows the relationship between the I Na peak and prepulse potential. The steady-state inactivation curve was then fitted using the Boltzmann equation of I Na /I Namax = 1/{1 + exp [(V m − V m 1 / 2 )/k]} + A. The normalized conductance as a function of the command potential, in the absence or presence of 10 μM PGE 2 or AA, is shown in Figures 6(C) and 6(D) . In the ten cells studied, the V m 1 / 2 values were − 60.6 + − 1.2 mV and − 61.0 + − 0.6 mV in the absence or presence of 10 μM PGE 2 respectively (P > 0.05). PGE 2 (10 μM) did not significantly shift the steady-state inactivation curve. 
COX inhibitors, flufenamic acid or indomethacin [NSAID (non-steroidal anti-inflammatory drug) members of different chemical groups]
, were used to block the COX pathway, probably with increased endogenous AA levels. Indomethacin or flufenamic acid alone in the pipette solution significantly decreased the I Na amplitude. Within 2 min after the establishment of the whole-cell configuration, the current amplitude was reduced by 18.3 + − 8.4 % (n = 4) and 14.9 + − 3.6 % (n = 5) (P < 0.05) respectively. A pipette solution containing 10 μM AA together with flufenamic acid or indomethacin compromised the AAinduced enlargement of I Na (Figures 7A and 7B) . Within the same time after the establishment of the whole-cell configuration, the current amplitude was slightly reduced by 5.1 + − 4.5 % (n = 6) and 4.7 + − 3.1 % (n = 6) in the presence of indomethacin plus AA or flufenamic acid plus AA respectively ( Figure 7C ).
Since previous reports demonstrated that the biological actions of AA could be mediated by PKC (protein kinase C) activation or intracellular Ca 2 + release [2, 5] , we explored the possibility of their involvement in intracellular AA-induced effects on I Na . Our results indicate that activation of PKC by intracellular perfusion of PMA did not change I Na of cerebellar GCs ( Figure 8A ). The I Na amplitude stabilized at − 751.2 + − 35.4 pA during 2 min of recording compared with 795.1 + − 50.3 pA before application (n = 4, P > 0.05). When caffeine (1 mM) was added to the bathing solution to stimulate the release of Ca 2 + from the endoplasmic reticulum ( Figure 8B ), I Na was rapidly reduced by 16.2 + − 1.6 % (n = 7, P < 0.05). In contrast, removing intracellular Ca 2+ by the recording pipette loaded with a Ca 2 + -free solution containing 10 mM BAPTA [1,2-bis-(o-aminophenoxy)ethane-N,N,N ,N -tetra-acetic acid] induced a gradual increase in the I Na amplitude from an initial value of 0.8 + − 0.1 nA, and reached a steady level of 1.1 + − 0.1 nA, a 40.7 + − 5.7 % increase ( Figure 8C ), suggesting that I Na is negatively regulated by an increase in intracellular Ca 2 + in cerebellar GCs. Statistical analysis of these results is shown in Figure 8(D) .
To address the question that PKA (protein kinase A) activation was involved in PGE 2 -induced modulation of I Na in rat cerebellar GCs, the effects of PGE 2 were investigated in the presence of the PKA inhibitors and activator respectively. Cytoplasmic delivery of 10 μM db-cAMP (dibutyryl cAMP), a membrane-permeable cAMP analogue, by the pipette solution mimicked the PGE 2 -induced effect on I Na ( Figure 9A ) and produced a significant increase (53.9 + − 6.0 %) of I Na. Furthermore, PGE 2 -or AAinduced increases of I Na were attenuated by applying a selective PKA antagonist H-89 ( Figures 9B and 9C) . After perfusion of H-89 (5 μM) by the pipette solution, PGE 2 and AA only increased I Na by 1.8 + − 1.6 % and 4.3 + − 1.1 % respectively (P > 0.05). In addition, the G s inhibitor NF449 (10 μM) could also block the increase in I Na induced by intracellular PGE 2 by 18.3 + − 5.1 % (n = 6) (P < 0.05, compared with intracellular PGE 2 alone). The cellular effects of PGE 2 are mediated through a family of G-protein-coupled receptors designated EP (E-series of prostaglandin) 1, EP2, EP3 and EP4 [28, 29] , among which EP2 and EP4 are related to activation of cAMP/PKA pathways [30] . We first used reverse transcriptase-mediated PCR analysis to demonstrate the presence of EP receptor mRNAs in cerebellar GCs and found that the four kinds of EP receptors are all expressed in GCs ( Figure 10A ). Because EP2 and EP4 can activate PKA pathways, we employed the EP2 and EP4 receptor antagonists AH6809 and AH23848 to investigate whether PGE 2 -induced PKA activation involved EP receptors. Bath infusion of AH6809 or AH23848 together with AA or PGE 2 in the pipette solution compromised the AA-induced and PGE 2 -induced augmentation of I Na (Figures 10B and  10C) . Within 2 min after the establishment of the whole-cell configuration, the current amplitude was significantly reduced by 20.1 + − 1.5 % (n = 5) and 26.5 + − 3.0 % (n = 7) in the presence of 25 μM AH6809 plus 10 μM AA, or 25 μM AH23848 plus 10 μM AA respectively (P < 0.05, compared with the control or intracellular AA alone). When applying 25 μM AH6809 plus 10 μM PGE 2 , or 25 μM AH23848 plus 10 μM PGE 2 , current amplitudes were reduced by 13.1 + − 2.0 % (n = 5) and 16.9 + − 4.7 % (n = 4) (P < 0.05, compared with intracellular PGE 2 alone). Statistical analysis of these data is shown in Figure 10 (D). Figure 11 is proposed as a model depicting the mechanisms that are likely to be involved in the modulation of I Na by extracellular/intracellular AA in cerebellar GCs.
DISCUSSION
Although the AA modulation of Na V has been reported previously [13, 37] , almost all of these studies have investigated only the effects of the extracellular application of AA. In the present paper, we report, for the first time, that both the extracellular and intracellular application of AA modulates I Na in rat cerebellar GCs and that two different non-metabolic or metabolic pathwaymediated mechanisms are involved.
Extracellular AA directly inhibits I Na and modifies Na V kinetics Several ion channels are known to be directly modulated by AA [10, 14, 31, 32] or indirectly modulated by its metabolites [33, 34] . In the present study, the action of extracellular AA was more likely to be a direct action because ETYA, which is the non-metabolized analogue of AA, presented similar modulatory effects on both the current amplitudes and activation properties of Na V . In addition, external AA-CoA, which is lipid insoluble and therefore unable to access the internal leaflet of the membrane, was observed to mimic external AA-induced I Na inhibition, suggesting that the inhibitory effects of extracellular AA on I Na were exerted without AA permeating into the cytoplasm. Finally, a previous report using electron microscope autoradiography to investigate the uptake of [ 3 H]AA from the extracellular fluid into cells demonstrated that the incorporation of radioactivity into the plasma membrane took at least several minutes [35] , supporting our hypothesis that extracellular AA is itself responsible for the observed effects on the Na V of GCs.
By observing the modulatory effect of extracellular AA on the activation properties of Na V in GCs, we noticed an increase in current amplitudes at low depolarizing potentials. This increase was probably caused by a leftward shift of Na V activation characteristics. In a previous investigation, AA, as a negatively charged compound, was reported to attract the voltage sensor of ion channels and facilitate channel opening [36] . As the three compounds that were used in the present study were all negatively charged, we infer that the observed shifts in the activation curve were probably induced by the lipoelectric tuning of voltage-sensor movement. Our observation differs from a previous report investigating DRG (dorsal root ganglion) neurons [37] , which indicated that the hyperpolarizing shift was caused by AA metabolites because ETYA did not induce a leftward shift in the activation curve, and a COX inhibitor prevented AAinduced shifts. Because a previous investigation indicated that the modulation of ion channel activity by AA depended on the type of cell studied [7] , we inferred that the difference between our observation and that made using DRG neurons could reflect the different sodium α-subunits involved therein: the fast TTX-S I Na in DRG neurons normally combines the subunits of sodium channels Na V 1.1, Na V 1.6 and Na V 1.7 [38] , and this clearly differs from the situation in rat cerebellar GCs [23] . In addition, the inhibitory effects of extracellular AA and ETYA were more potent than that of extracellular AA-CoA, whereas AA-CoA shifted the activation curve of Na V slightly more in the hyperpolarizing direction than AA and ETYA. This could be explained by the large molecular size of CoA, which may reduce the access of the fatty acid to fill the spaces that are required for its activity. This restricted access may result in a modulation of channel function in a manner that is slightly different from that by AA and ETYA [39] .
Intracellular AA increases I Na in GCs via metabolic pathways
Few investigations to date have measured the effects of intracellular AA on I Na . We report that the cytoplasmic delivery of AA significantly augments I Na in a concentration-dependent manner over a period of 2-3 min. In addition to augmenting I Na amplitudes, intracellular AA significantly shifts the conductancevoltage relationship curves in the hyperpolarizing direction; however, EYTA, which is an AA analogue that cannot be metabolized by the three common pathways that are known to generate biologically active products (COX, lipoxygenase and cytochrome P450 epoxygenase pathways), produces a similar modulatory effect with extracellular AA, no matter how ETYA is applied. These results indicate that the mechanisms that are involved in the activation of I Na by intracellular AA differ from those utilized when extracellular AA is applied and are probably not affected by the AA molecule itself.
COX-2 has been reported to be abundant in brain neurons [27] . In addition, PGE 2 increases the amplitude of the TTX-resistant Na + current, lowers the activation threshold of the current and increases its rate of activation and inactivation [40, 41] . Therefore we hypothesized that intracellular AA regulates I Na via conversion into PGE 2 . As expected, the intracellular application of PGE 2 reproduced the effects of AA on I Na , including an observed increase of current amplitude and a change in the steady-state activation characteristics, which is consistent with our hypothesis. In addition, the two COX inhibitors both eliminated the AAinduced stimulation of I Na , further suggesting that it is a metabolite of AA that increases I Na and not AA itself.
Intracellular AA augments the activity of Na V via the PGE 2 -mediated activation of cAMP/PKA pathways It has been reported that AA could induce the activation of PKC and intracellular Ca 2 + release; however, in the present study, the activation of PKC by PMA did not affect I Na amplitudes, indicating that the intracellular AA-induced increase was not mediated by the PKC pathway. Moreover, we found that the intracellular Ca 2 + level and I Na amplitudes were negatively correlated, an increasing intracellular Ca 2 + level resulted in reduced I Na amplitudes and the chelation of intracellular Ca 2 + increased I Na amplitudes. This phenomenon implies that the intracellular AA-induced I Na increase was not related to intracellular Ca 2 + release. It is well known that Na V activities can be modulated by cAMP/PKA pathways because the α-subunits of Na V channels are preferred substrates for phosphorylation by cAMP/PKA [42] . The activation or inhibition of Na V channels depends on the cell model studied [41, 43] ; however, our proposal that intracellular AA augments the activity of Na V via PGE 2 -mediated activation of cAMP/PKA pathways differs from the conclusion drawn by Cantrell and Caterall [44] , which was that the activity of the wildtype brain IIA Na + channel is attenuated by PKA phosphorylation. There are at least two possible explanations for this contradiction. First, because it has been reported that the majority of I Na in cerebellar GCs are mediated by the Na V subunits Na V 1.2 and Na V 1.6 [23] , the composition of Na V on cerebellar GCs is more complicated than the brain IIA Na + channel, which may result in different reactions. Secondly according to Smith and Goldin [45] , the brain IIA Na + channel is functionally modulated by PKA activity in two distinct ways, resulting in either a decrease or an increase in Na + current amplitudes depending on the phosphorylation status of the I-II linker before the PKA is activated; additional activation of PKA might trigger a secondary mechanism that potentiates current when the basal level of phosphorylation is sufficient to phosphorylate the I-II linker sites. Thus it is possible that the apparently contradictory modulation may be caused by different physiological conditions. PGE 2 acts through four G-protein-coupled receptors that are designated EP1-EP4. We observed that all four PGE 2 receptors are expressed in cerebellar GCs; however, only EP2 and EP4 influence adenylate cyclase and cAMP induction. EP3 activation can result in the inhibition or (rarely) elevation of cAMP levels, and EP1 is coupled to Ca 2+ mobilization [30] . Because cAMP could mimic the intracellular AA/PGE 2 -induced I Na increase, and because neither PKC nor Ca 2 + were involved in intracellular AA modulation, we focused on the EP2 and EP4 receptors and found that EP2 and EP4 antagonists could significantly eliminate the intracellular AA/PGE 2 -induced I Na increase. Considering all of the above results, we inferred that intracellular AA increased I Na after conversion into PGE 2 , via activation of the cAMP/PKA pathway.
In summary, the results of the present study show, for the first time, that AA, via its metabolites, can modulate I Na by activating PGE 2 -induced cAMP/PKA pathways in neurons.
Physiological implications
The Na V channels are not only responsible for the initiation and propagation of action potentials in a wide variety of excitable neurons, but also contribute to the aetiology of neurological disease and to many cellular processes, including apoptosis, motility and secretory membrane activity. In the present study, the rapid and direct action of extracellular AA inhibits I Na , indicating that exogenous AA uptake or a massive amount of AA that is secreted by surrounding cells under pathological situations would increase the threshold for action potential and lower neuron excitability. In contrast, when AA is liberated from membrane phospholipids by various physiological or pathological stimuli and converted into prostanoids, neuron excitability would be improved. In addition, the molar ratio of AA to its prostaglandin metabolites is probably an important factor in determining the activity of AA. Because the inhibition of the COX pathway in the AA cascade can cause an accumulation of AA and/or reduce the production of prostaglandins [46] , both of the two COX inhibitors that were used in the present study significantly inhibited I Na . In contrast with intracellular AA, internal ETYA inhibits I Na . Thus we presume that internal AA molecules can inhibit I Na before being metabolized. At higher concentrations of COX inhibitors, the levels of AA markedly exceeded the levels of PGE 2 that were generated by AA metabolism, which led to a greater degree of current amplitude inhibition (results not shown). In addition, with an equal concentration of EPreceptor antagonists in the bath, intracellular AA induced a greater inhibition on I Na than intracellular PGE 2 . The molar ratio of AA to its metabolite(s) could therefore be an important factor determining whether intracellular AA enhances or suppresses the excitability of neurons. This could partly explain why AA exhibited distinct neurotoxic or neurotrophic actions over a narrow concentration range in the study of Katsuki and Okuda [1] .
Nevertheless, the modulations of neuron ion channel activities by AA are complicated and various. We previously observed the effects of extracellular and intracellular AA on I A in rat cerebellar GCs, and these observations indicated more than one mechanism for the action of AA [47, 48] . Therefore further exploration is required to comprehensively analyse the physiological role of AA in neuron modulation.
